USE OF VISHTINDUKADI VATI AND TAGARADI KWATH GHAN VATI ALONGWITH ABHYANGA AND SHIRODHARA IN THE MANAGEMENT OF AHIPHENE VYASANA (OPIUM DE-ADDICTION)

CLINICAL EVALUATION OF VISHTINDUKADI VATI AND TAGARADI KWATH GHAN VATI ALONGWITH ABHYANGA AND SHIRODHARA IN THE MANAGEMENT OF AHIPHENE VYASANA (OPIUM DE-ADDICTION)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/038055

Enrollment

Registered

2021-11-15

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F112- Opioid dependence

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed Patient of opium addiction. Age between 16-70 year. Patient willing to give consent for clinical trial.

Exclusion criteria

Exclusion criteria: Opium addicted patients who are suffering from major psychiatric disorder. Opium addicted patients suffering from major systemic illness like myocardial infraction, Ischemic heart disease, Hypertension, Tuberculosis, Bronchial Asthma, HIVAIDS, Cancer, Major respiratory disease, liver failure, Renal failure and Renal toxicity etc.

Design outcomes

Primary

Measure	Time frame
Primary Outcome of patients will be done on the basis of COWS Scale- Craving for an Opium Insomnia Muscle ache/Cramps etc... The withdrawal symptoms will be assessed by grading system grade o- Absent grade 1- Mild grade 2- Moderate grade 3- Severe grade 4-Fatal.Timepoint: 21 days	—

Secondary

Measure	Time frame
To find out the efficacy of treatment- Serum Opium Estimation CBC Complete Urine Examination Blood Investigation...Timepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Jitendra sankhla

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Karwar, Jodhpur, Rajasthan

drritukapoor4@gmail.com7976967729

Outcome results